{"isDivestment":"true","_id":"887afb2c-7759-4fe0-bbff-a3a6d0d8e78e","country":"Finland","entryDate":"2012-10-01","exitDate":"2015-09-01","path":"/current-portfolio/vertu/","sector":"Consumer goods","title":"Vertu","organizationData":{},"organisationDetails":{"slug":{"current":"vertu"},"board":[],"detailedDescription":"This renewed customer centric strategy has resulted in a successful improvement of VERTU\u0027s luxury brand positioning. In October 2015 EQT VI completed the sale of VERTU to a group of international private investors."},"fundData":[{"title":"EQT VI"}]}
{"isDivestment":"true","_id":"a22017a2-4617-46f8-9dfe-ef782a62b93e","country":"Netherlands","entryDate":"2018-11-01","exitDate":"2020-10-01","path":"/current-portfolio/veritas-petroleum-services-vps/","sector":"Services","title":"Veritas Petroleum Services (VPS)","organizationData":{},"organisationDetails":{"slug":{"current":"veritas-petroleum-services-vps"},"board":[],"detailedDescription":"EQT Credit, through its Mid-Market Credit investment strategy, committed a USD95m senior unitranche facility to refinance existing debt. In addition, EQT Credit has provided committed acquisition facilities to support the Company’s future growth plans. To  VPS"},"fundData":[{"title":"EQT Mid-Market Credit"},{"title":"EQT Mid-Market Credit II"}]}
{"isDivestment":"true","_id":"15cdc6f0-0fbf-4796-a5ba-27a36b83df90","country":"Denmark","entryDate":"2014-03-01","exitDate":"2017-08-01","path":"/current-portfolio/faerch-plast/","sector":"Consumer goods","title":"Færch Plast","organizationData":{},"organisationDetails":{"slug":{"current":"faerch-plast"},"board":[],"detailedDescription":"Following the acquisitions of Anson Packaging and Sealed Air’s European tray business in 2015, the company has 7 production sites located in Denmark, the UK, the Czech Republic and Spain serving the European market and employs more than 1,100 people with local operations in more than 15 countries. Færch Plast offers a full-range of rigid plastic trays in all major plastic resins (i.e. CPET, APET, PP, PP with barriers) which translates into an extensive product catalogue of more than 3,000 different trays. The company was founded in 1969 by Rasmus Færch and has since then grown and evolved into the current European leader of innovative and optimized packaging solutions with a core focus on recyclability, sustainability and food safety. To  Færch Plast"},"fundData":[{"title":"EQT VI"}]}
{"isDivestment":"true","_id":"611d22aa-0f2c-468e-a834-c5499a95fc23","country":"Ireland","entryDate":"2015-10-14","exitDate":"2021-12-20","path":"/current-portfolio/nordic-aviation-capital/","sector":"Services","title":"Nordic Aviation Capital","organizationData":{},"organisationDetails":{"slug":{"current":"nordic-aviation-capital"},"website":"http://www.nac.dk/","board":[],"detailedDescription":"About NAC  NAC provides leasing and lease management services to airlines and aircraft investors worldwide. Aircraft are purchased in the primary and secondary markets and NAC is the largest regional fleet owner and aircraft lessor in the world. Through a focused strategy on turboprop aircraft and regional jets combined with strong in-house technical and commercial skills, NAC has been capable of delivering impressive top- and bottom-line growth by having strict focus on efficient portfolio management, strong relationship to OEMs and ability to meet the need for flexible and innovative financing solutions for regional aircraft customers across the world."},"fundData":[{"title":"EQT VI"}]}
{"isDivestment":"true","_id":"f27db321-bcdc-4341-8330-5264c6f53886","country":"United States","entryDate":"2017-03-01","exitDate":"2021-03-01","path":"/current-portfolio/dorner/","sector":"Industrial Technology","title":"Dorner","organizationData":{},"organisationDetails":{"slug":{"current":"dorner"},"board":[],"detailedDescription":"The Company commands a strong growth profile due to favorable underlying automation trends combined with an array of high-quality product offerings sold through multiple channels. Dorner is the US market leader in its core industrial automation product lines, in which it provides precision conveyor systems used for light and medium duty material handling applications across a variety of end markets. Additionally, the company has a leading position in its sanitary product line, in which it is one of two providers that offer USDA-certified conveyor systems, primarily used for applications which require sanitary material handling capabilities in the food \u0026 beverage and pharmaceutical markets. Dorner has a strong brand name and a reputation for innovative engineering, evidenced by leading performance across customers’ key purchasing criteria and high customer satisfaction scores. The Company has over 300 employees and is headquartered in Hartland, Wisconsin, with additional offices in Canada, Mexico, Germany and Malaysia."},"fundData":[{"path":"/current-portfolio/funds/eqt-mid-market-us/","title":"EQT Mid Market US","preamble":"EQT Mid Market US makes control and co-control equity investments in high-quality companies with strong market positions, significant potential for revenue and earnings growth, strong cash flows and a solid platform that can retain and / or attract high quality management.\n","currency":"usd","email":"peter.veldman@eqtfunds.com","heading":"Investments range between USD 50 million and USD 150 million per investment","indexing":"index,follow","launchDate":"2016","size":"695","status":"fullyinvested"}]}
{"isDivestment":"false","_id":"b133af2d-27dd-4a0c-b41e-a13994aa76f6","country":"Germany","entryDate":"2021-03-06","path":"/current-portfolio/ariceum-therapeutics/","sdg":[],"sector":"Healthcare","title":"Ariceum Therapeutics","organizationData":{"uuid":"e9901b38-f393-4072-8b05-e2da8d7d0e94","name":"Ariceum Therapeutics","homepage_url":"https://ariceum-therapeutics.com/","country_code":"DEU","city":"Berlin","founded_on":"2021-01-01","short_description":"Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.","employee_count":"11-50","num_funding_rounds":"2","last_funding_on":"2023-04-18","total_funding_usd":"51760502"},"organisationDetails":{"slug":{"current":"ariceum-therapeutics"},"website":"https://ariceum-therapeutics.com/","board":[]},"fundData":[{"path":"/current-portfolio/funds/lsp-7/","title":"LSP 7","preamble":"LSP 7 seeks to invest in early-to-late-stage life sciences companies, developing novel and ground-breaking new medicines and technologies that provide solutions to unmet medical needs. LSP 7’s geographical focus is primarily Europe and occasionally the US. \n","currency":"eur","email":"rkuijten@lspvc.com","heading":"Investments range between EUR 30 million and EUR 60 million","indexing":"index,follow","launchDate":"2021","size":"1000","status":"active"}]}
{"isDivestment":"true","_id":"4859d0ef-5ac1-4a88-8a2a-e59c76f8d071","country":"United States","entryDate":"2019-10-11","exitDate":"2021-08-30","path":"/current-portfolio/aldevron/","sector":"Healthcare","title":"Aldevron","organizationData":{},"organisationDetails":{"slug":{"current":"aldevron"},"website":"https://www.aldevron.com/","board":[],"detailedDescription":"About Aldevron  Founded in 1998 by Michael Chambers and John Ballantyne, Aldevron is the leading global supplier of GMP, GMP-SourceTM and Research Grade plasmid DNA used in commercial, clinical and research stage gene therapies, as well as proteins, antibodies and mRNA. The company’s mission is to develop and manufacture biologics at the highest quality that help make meaningful changes worldwide, and its custom development and manufacturing capabilities enable scientists to develop groundbreaking new therapies. Aldevron is based in Fargo, North Dakota and has additional operations in Madison, Wisconsin and Freiburg, Germany. The Company serves leading academic and research institutions, pharmaceutical and biotechnology companies."},"fundData":[{"path":"/current-portfolio/funds/eqt-viii/","title":"EQT VIII","preamble":"EQT VIII makes control equity investments as well as significant influence investments in companies with strong market positions, significant potential for revenue and earnings growth, strong cash flows and a solid platform that can retain and attract high-quality management. The geographical focus will primarily be Northern Europe and the fund will mainly focus on investments in the Healthcare, TMT and Services sectors.\n","currency":"eur","email":"peter.veldman@eqtfunds.com","heading":"Investments range between EUR 150 million and EUR 1,000 million","indexing":"index,follow","launchDate":"2018","size":"10910","status":"fullyinvested"}]}
{"isDivestment":"true","_id":"610e7d93-5285-48f5-9a4e-5435fa33bc0b","country":"Hong Kong","entryDate":"2017-03-15","exitDate":"2022-09-19","path":"/current-portfolio/gpa-global/","sector":"Services","title":"GPA Global","organizationData":{},"organisationDetails":{"slug":{"current":"gpa-global"},"website":"https://gpaglobal.net/","board":[],"detailedDescription":"About GPA Global  Founded in 2009, the company has achieved strong sales and EBITDA growth and established a rapidly growing list of customers in the consumer electronics, mobile accessories and games \u0026 toys sectors. GPA Global is focused on blue-chip / high-growth SMEs in the US and China, but has also attracted bigger customers with USD five million annual packaging budgets. EQT acquired a co-control stake in GPA Global in 2017 and is currently the single largest shareholder of the company."},"fundData":[{"path":"/current-portfolio/funds/eqt-mid-market-asia-iii/","title":"EQT Mid Market Asia III","preamble":"EQT Mid Market Asia III targets control or co-control investments in high-quality, medium-sized companies in Greater China and Southeast Asia with attractive value creation and growth potential.\n\n","currency":"usd","email":"peter.veldman@eqtfunds.com","heading":"Seeks investments with an enterprise value between USD 30 million and USD 250 million","indexing":"index,follow","launchDate":"2018","size":"737","status":"active"}]}
{"isDivestment":"false","_id":"6c656c93-c6be-46ed-b6e6-4d605dda93b0","country":"United Kingdom","entryDate":"2022-03-15","path":"/current-portfolio/fundamental-vr/","sdg":[],"sector":"Healthcare","title":"Fundamental VR","organizationData":{},"organisationDetails":{"slug":{"current":"fundamental-vr"},"website":"https://fundamentalsurgery.com/","board":[]},"fundData":[{"path":"/current-portfolio/funds/lsp-hef-2/","title":"LSP HEF 2","preamble":"LSP HEF 2 (Health Economic Fund) seeks to invest in health care technology companies in late-stage development or early-stage commercialization. Products or technologies need to have the potential to improve the quality of healthcare and lower the cost of care at the same time. LSP HEF 2’s geographical focus is primarily Europe and the US. \n","currency":"eur","email":"rdekeyser@lspvc.com","heading":"Investments range between EUR 10 million and EUR 30 million","indexing":"index,follow","launchDate":"2018","size":"280","status":"active"}]}
{"isDivestment":"true","_id":"b942c7d8-09c1-411b-9720-2908daf262d6","country":"Sweden","entryDate":"2018-04-11","exitDate":"2021-07-02","path":"/current-portfolio/iver/","sector":"TMT","title":"Iver","organizationData":{},"organisationDetails":{"slug":{"current":"iver"},"website":"https://www.iver.com/","board":[],"detailedDescription":"About Iver  Iver is a leading Swedish managed IT services provider with capabilities for full IT outsourcing, providing their clients with contracted services, including hosting, cloud and application management. Iver has managed to build strong customer relationships in Sweden and Norway by combining dedicated customer focus with high quality IT solutions. Iver was formed in April 2018 by combining Candidator and DGC IT Services, creating a leading Nordic managed IT services provider. Both companies have strategically complementary characteristics from DGC IT Services’ strong position in the public and finance customer verticals in Eastern Sweden and Candidator’s stronghold in Western and Southern Sweden. Since the combination, five additional add-ons, including Solid Park, have been completed."},"fundData":[{"path":"/current-portfolio/funds/eqt-mid-market-europe/","title":"EQT Mid Market Europe","preamble":"EQT Mid Market Europe targets control or co-control investments in high-quality, medium-sized companies in Northern Europe (including the Nordics, DACH and the Benelux) with attractive value creation and growth potential. ","currency":"eur","email":"peter.veldman@eqtfunds.com","heading":"Seeks investments with an enterprise value between EUR 100 million and EUR 300 million","indexing":"index,follow","launchDate":"2017","size":"1616","status":"active"}]}
{"isDivestment":"false","_id":"1108b4d9-6102-497c-b1b9-21b51b63dcc9","country":"Sweden","entryDate":"2019-01-16","path":"/current-portfolio/karo-healthcare/","sdg":[],"sector":"Healthcare","title":"Karo Healthcare","organizationData":{"uuid":"da941769-eda4-4d29-9e72-4427d9f504af","name":"Karo Healthcare","homepage_url":"https://www.karopharma.com","country_code":"SWE","city":"Stockholm","founded_on":"1987-01-01","short_description":"Karo Healthcare is a health care center that develops and markets products to pharmacies.","employee_count":"101-250"},"organisationDetails":{"slug":{"current":"karo-healthcare"},"website":"https://www.karohealthcare.com/","board":[{"title":"Chairperson","name":"Kåre Schultz"},{"title":"Board member","name":"Pat Smallcombe"},{"title":"Board member","person":{"title":"Erika Henriksson"}},{"title":"Board member","name":"Uta Kemmerich-Keil"},{"title":"Board member","name":"Mark Keatley"},{"title":"Board member","name":"Claire Hennah"}],"detailedDescription":"About Karo Healthcare  Karo Healthcare sells and markets a portfolio of everyday healthcare products that help prevent illnesses and treat health problems. The portfolio consists of original brands with strong market positions and comprises both prescription drugs (Rx) as well as consumer products (OTC) within seven distinct categories - Skin Health, Intimate Health, Digestive Health, Foot Health, Wellness, Pain, Cough \u0026 Cold and Specialty products. Karo Healthcare\u0027s products have a strong position in the Nordic regions and the company has successfully expanded its direct distributions network to several other countries in Western Europe both through organic growth and acquisitions. Overall, Karo Healthcare\u0027s products are sold to sixty different markets worldwide. Karo Healthcare was founded in 1987 and is headquartered in Stockholm, Sweden.  Market trends and drivers  The large specialty pharmaceutical market demonstrates stable growth over the cycles and high resilience during economic downturns. The market offers attractive growth opportunities, both organically driven by underlying patient-critical demand, and inorganically through a generally high M\u0026A activity as a result of the continued consolidation in the pharmaceutical industry. Investment potential  Accelerate organic growth in existing portfolio through commerical and digital focus, primarily on larger \"Hero\" brands with international presence and potential. Continue consolidating the fragmented speciality pharma and consumer health market by acquiring pan-European brands in core categories with growth potential, targeting attractive organic growth outlook at exit. Increase share of OTC in the overall portfolio. Drive operational improvements including increasing gross margin through CMO and logistics consolidation, as well as driving operating leverage while strengthening Karo Healthcare\u0027s organization and capabilities."},"fundData":[{"path":"/current-portfolio/funds/eqt-viii/","title":"EQT VIII","preamble":"EQT VIII makes control equity investments as well as significant influence investments in companies with strong market positions, significant potential for revenue and earnings growth, strong cash flows and a solid platform that can retain and attract high-quality management. The geographical focus will primarily be Northern Europe and the fund will mainly focus on investments in the Healthcare, TMT and Services sectors.\n","currency":"eur","email":"peter.veldman@eqtfunds.com","heading":"Investments range between EUR 150 million and EUR 1,000 million","indexing":"index,follow","launchDate":"2018","size":"10910","status":"fullyinvested"}]}
{"isDivestment":"false","_id":"2ad70473-2924-4d48-9e09-938ee2926b69","country":"United States","entryDate":"2020-08-14","path":"/current-portfolio/workwave/","sdg":[],"sector":"Technology","title":"WorkWave","organizationData":{"uuid":"a0af0753-feb7-ab7d-d2f3-95722adad41d","name":"WorkWave","homepage_url":"https://www.workwave.com/","country_code":"USA","city":"Holmdel","founded_on":"1984-01-01","short_description":"WorkWave provides cloud-based software solutions that support every stage of a service business’s life cycle.","employee_count":"1001-5000","num_funding_rounds":"5","last_funding_on":"2022-03-30","total_funding_usd":"8300000"},"organisationDetails":{"slug":{"current":"workwave"},"website":"https://www.workwave.com/","board":[{"title":"Chairperson","name":"Darren Roos"},{"title":"Board member","name":"Sejal Pietrzak"},{"title":"Board member","name":"Sheryl Hoskins"},{"title":"Board member","name":"Eric Palmer"}],"detailedDescription":"About  Founded in 1984, WorkWave is a leading provider of software and related digital solutions to recurrent service verticals within field service management (FSM). WorkWave’s solutions empower companies in their target verticals to reach their full potential through scalable, cloud-based software solutions that support every stage of their business life cycle, including marketing, sales, service delivery, customer interaction and financial transactions. Market trends and drivers  WorkWave operates within the FSM market that benefits from global thematic trends like digitization \u0026 automation, rising cloud adoption and sustainability. WorkWave’s solutions enable their customers to manage their resources and assets more efficiently, thereby growing their businesses in a sustainable way. Moreover, WorkWave has successfully been able to benefit from the shift towards integrated payments, offering end-customers a seamless combined software and payments experience. Investment potential  In 2021, WorkWave was separated from IFS into a standalone EQT portfolio company, in order to unleash the full value creation potential of the business with standalone governance and focus. Since the separation WorkWave has accelerated its already rapid growth. WorkWave has made three transformation add-ons, gone from being the leader in one vertical to being it in all main asset light field service management verticals, and also successfully expanded its ecosystem around the software including payments and market places."},"fundData":[{"path":"/current-portfolio/funds/eqt-ix/","title":"EQT IX","preamble":"EQT IX makes control and co-control equity investments in mid-to-large sized companies with attractive market positions, significant potential for revenue and earnings growth, strong cash flows and a solid platform that can retain and attract high-quality management.\n","currency":"eur","email":"peter.veldman@eqtfunds.com","heading":"Investments range between EUR 150 million and EUR 1,200 million","indexing":"index,follow","launchDate":"2020","size":"15600","status":"active"},{"path":"/current-portfolio/funds/eqt-viii/","title":"EQT VIII","preamble":"EQT VIII makes control equity investments as well as significant influence investments in companies with strong market positions, significant potential for revenue and earnings growth, strong cash flows and a solid platform that can retain and attract high-quality management. The geographical focus will primarily be Northern Europe and the fund will mainly focus on investments in the Healthcare, TMT and Services sectors.\n","currency":"eur","email":"peter.veldman@eqtfunds.com","heading":"Investments range between EUR 150 million and EUR 1,000 million","indexing":"index,follow","launchDate":"2018","size":"10910","status":"fullyinvested"}]}
